NuOncology Labs, Inc. engages in the research, development, testing, and licensing of cancer treatments, and medical and agricultural compounds; and the delivery of predictive chemosensitivity tests, as of December 31, 1998. It served surgeons, oncologists, pathologists, hospitals, health maintenance organizations, community health centers, and third party insurance companies in the United States.